Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186883 | SCV000240454 | uncertain significance | not provided | 2020-09-15 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge; Observed in 0.0048% (12/251472 alleles) in large population cohorts (Lek et al., 2016) |
Labcorp Genetics |
RCV000691513 | SCV000819296 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317070 | SCV000851714 | likely benign | Inborn genetic diseases | 2020-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |